Original paper
Multi-Center Experience of Vedolizumab Effectiveness in Pediatric Inflammatory Bowel Disease
Abstract
Though vedolizumab has received regulatory approval for the treatment of Crohn's disease (CD) and ulcerative colitis (UC) in adults, there is increasing off-label use in children. To describe the experience with vedolizumab in pediatric inflammatory bowel disease (IBD) patients at 3 tertiary IBD centers and examine predictors of remission. A retrospective review identified pediatric IBD patients (age < 18 yrs) receiving vedolizumab. Data on...
Paper Details
Title
Multi-Center Experience of Vedolizumab Effectiveness in Pediatric Inflammatory Bowel Disease
Published Date
Sep 1, 2016
Journal
Volume
22
Issue
9
Pages
2121 - 2126
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History